Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Outset Medical, Inc. before investing.

In this article, we go over a few key elements for understanding Outset Medical, Inc.’s stock price such as:

• Outset Medical, Inc.’s current stock price and volume
• Why Outset Medical, Inc.’s stock price changed recently
• Upgrades and downgrades for OM from analysts
• OM’s stock price momentum as measured by its relative strength

About Outset Medical, Inc. (OM)

Before we jump into Outset Medical, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Want to learn more about Outset Medical, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Outset Medical, Inc..

Outset Medical, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 12:56 PM, CST, Outset Medical, Inc.’s stock price was $4.620.

Outset Medical, Inc. is down 2.74% from its previous closing price of $4.750.

During the last market session, Outset Medical, Inc.’s stock traded between $4.469 and $4.790. Currently, there are approximately 18.37 million shares outstanding for Outset Medical, Inc..

Outset Medical, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Outset Medical, Inc. Stock Price History

Outset Medical, Inc.’s (OM) price is currently up 6.94% so far this month.

During the month of July, Outset Medical, Inc.’s stock price has reached a high of $5.530 and a low of $3.960.

Over the last year, Outset Medical, Inc. has hit prices as high as $17.200 and as low as $3.000. Year to date, Outset Medical, Inc.’s stock is up 24.53%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Outset Medical, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded Outset Medical, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Outset Medical, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Outset Medical, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Outset Medical, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Outset Medical, Inc. (OM) by visiting AAII Stock Evaluator.

Relative Price Strength of Outset Medical, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Outset Medical, Inc. has a weighted four-quarter relative price strength of -18.00%, which translates to a Momentum Score of 14 and is considered to be Very Weak.

Want to learn more about how Outset Medical, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Outset Medical, Inc. Stock Price: Bottom Line

As of July 31, 2026, Outset Medical, Inc.’s stock price is $4.620, which is down 2.74% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Outset Medical, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.